Experimental Studies on the Anti-tumor and the Immunomodulatory Effects of Jiaweicitaowan(加未慈桃丸)

가미자도환(加味慈桃丸)의 항암(抗癌) 및 면역증강효과(免疫增强效果)에 관한 부험적(實驗的) 연구(硏究)

  • Jeon, Young-Soo (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Shim, Bum-Sang (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Choi, Seung-Hoon (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Ahn, Kyoo-Sook (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University)
  • 전영수 (경희대학교 한의과대학 병리학교실) ;
  • 심범상 (경희대학교 한의과대학 병리학교실) ;
  • 최승훈 (경희대학교 한의과대학 병리학교실) ;
  • 안규석 (경희대학교 한의과대학 병리학교실)
  • Published : 2002.12.30

Abstract

This experimental study was carried out to evaluate the anti-tumor and the immunomodulatory effects of Jiaweicitaowan(加未慈桃丸) against cancer. The in vitro anti-tumor effects were evaluated by MTT assay. The cytotoxicity, extension of survival days, the effect of inhibition solid tumor which was induced sarcoma 180, and the changes of body weight were evaluated for in vivo effects of anti-tumor. To evaluate the immunomodulatory effects of Jiawei- citaowan(加未慈桃丸), delayed type hypersensitivity, hemagglutinin, hemolysin titers for humoral immune response, rosette forming cells for cell-mediated immune response, natural killer cell activity, proliferation of lymphocyte, productivty of Interleukin-2, and carbon clearance were measured with methotrexate treated mice. The results were as follows; 1. In the case of existence ability of tumor cell, IC50 had an anti-tumor ativity resulted 2.52mg/ml to SNU-C4. 0.41mg/ml to SNU-396, resulted to 0.09mg/mlSNU-1. 2. The groups of Jiaweicitaowan(加未慈桃丸) 10mg/ml, 20mg/kg had no body weight loss. reduction in intake of water and feed, so these had no toxicity. 3. In the case of the effect of extention of existence. the group of 20mg/kg Jiaweicitaowan(加未慈桃丸) extract treated group was showed 250% in ILS. 4. The effect of inhibition solid tumor was significantly decreased in both 10mg/kg, 20mg/kg of Jiaweicitaowan(加未慈桃丸) extract treated groups as compared with control group S. The groups of 10mg/kg, 20mg/kg Jiaweicitaowan(加未慈桃丸) had significant effect of body weight change compared to control group. 6. Delayed type hypersensitivity was not significant in both Jiaweicitaowan(加未慈桃丸) extract treated groups as compared with control group. 7. Hemagglutinin and Hemolysin titers were significantly increased by dose-dependent. so these results showed that the humoral immume respose was activated. 8. For the effect of rosette formimg cells was not significant in hoth Jiaweicitaowan(加未慈桃丸) extract treated groups as compared with control group. 9. Natural killer cell activity was significantly increased in both Jiaweicitaowan(加未慈桃丸) extract treated groups as compared with control group in the ratio of 100: 1, 50: 1 of effector and target cells, but in the ratio of 10:1, the Jiaweicitaowan(加未慈桃丸) extract treated groups were not significant. 10. The proliferation of lymphocyte and productivty of Interleukin-2 were significantly increased by dose-dependent in both 10mg/ kg, 20mg/ kg of Jiaweicitaowan(加未慈桃丸) extract treated groups as compared with control group. 11. In the phagocytic effect, the 20mg/kg of Jiaweicitaowan(加未慈桃丸) extract treated group showed the increasing effect with significance as compared with control group. According to the results, we can suggest that Jiaweicitaowan(加未慈桃丸) has the antitumor and the immunomodulatory effects.

Keywords

References

  1. 息富九 및 肥氣九이 白血病과 淋巴雇患者에서 抽出한 德細胞에 미치는 效果 姜大根
  2. 인간생명과학 박재갑
  3. 대한면역학회지 v.6 no.1 정상인및 암환자의 자연살해능력에 관한 연구 김진복(외)
  4. 종양학 서울대학교 의과대학
  5. 대한동의병리학회지 v.10 사물탕의 항앙제부작용 억제에 관한 실험적연구 안희덕;최승훈;안규석
  6. 면역항진효과 검정방법:전통약물로 부터 신약개발 연구법 양규환
  7. 대한의학협회지 v.32 no.3 최근한국의 질병변천 이문호(등)
  8. 내과학 이문호(외)
  9. 약리학강의 이우주
  10. 본초학 전국한의과대학 본초학교수(공편)
  11. 東醫病理學會誌 v.9 隔下逐努湯과 順下逐寮湯合四君子湯의 抗感 및 免疫調節作用에 관한 實驗的 硏究 고광석;최승훈;문준전;안규석
  12. 伏梁丸이 白血病과 淋巴雇患者에서抽出한 痛,炯胞에 미치는 效果 金剛山
  13. 肥氣丸 및 消積正元散이 사람의 各種 德細胞株의 歲長沮碍에 미치는 效果 金剛山
  14. 趙永직 博士 華甲紀論文集 敎種 韓需材가 制痛劑 및 Glucocorticoid의 狀駱生産抑制作用에 미 치는 影響 金光湖(외)
  15. 紫玆이 抗流作用 및 免疫反應에 미치는 影響 金尙勳
  16. 대한면역학회지 v.5 no.1 암환자에서의 T,K, NK세포 및 단구의 기능저하 김재광(외)
  17. 96 International Symposium of Traditional Chinese Medicine on Oncology v.11 蔘凉扶正湯의 방사선 조사로 손상된 조직 회복 및 조혈촉진 효과 김정수;최승훈
  18. 대한면역학회지 v.6 no.1 정상인 및 암환자의 자연살해능력에 관한 연구 김진복(외)
  19. 四妙湯 大紫胡湯 및 構成藥劑들의抗癩作用과 免疫反應에 관한 實驗的 硏究 김한섭
  20. 大韓韓方緩崙學會誌 v.2 no.1 消積保中九의 抗緩崙效果에 대한 叢驗的 硏究 魯勳政(외)
  21. 半夏白添天默湯과 牢夏白恭天流湯加味方의 抗寢效果와 免疫反應에 관한實驗的 硏究 自泰鎔
  22. 證芝 山慈蒸 鶴草 卷柏 瓦松이孫編皓 感崙性에 미치는 影響 吳千植
  23. 六君子湯, 小梁胡湯, 魚賤草 및 加味方의 抗孫作用과 免疫反應에 관한 責驗的 硏究 尹相協
  24. 大韓韓方獲鑛學會誌 v.2 no.1 息貴湯이 抗偏 및 免凌調節作用에미치 는 影響 尹星默
  25. 大韓韓方雇療學會誌 v.2 no.1 放射線 照財後의N:GP(S)mouse 脚臟細織 增殖에 미치는 補中益氣湯과 四六湯의 效果 이능기;崔昇勳
  26. 防毒湯의 抗麗街效果와 免疫反應에 관한 實驗的 硏究 李鳳雨
  27. 韓韓方履鑛學會誌 v.2 no.1 消積白端散을 投與한 各種 崙患者 242例大에 대한 臨床的 考寮 李洲月;趙鍾寬
  28. 巴豆를 加味한 四君子湯 및 四物湯의 抗漂效果에 대한 硏究 李永燥
  29. 病原微生物學 李鍾訓
  30. 東風菜가 抗癌作用 및 免疫反應에미치는 影響 李學喆
  31. 數種의 韓襲物이 感細胞 感受性에 미치는 影響 任宰訓
  32. 修治巴豆 및 巴豆加崙速의 絲胞毒性과 抗履崙效果에 관한 賃驗的硏究 趙誠珏
  33. 인삼의 약리연구 및 효능연구 인삼 Crude Saponin이 저하된 변역반응 및 망내계 기능의 회복에 미치는 영향 조혁규
  34. 東醫賤寡學 崔昇勳
  35. 內經病理學 崔昇勳
  36. 대한한방종양학회지 v.1 no.1 한의학의 종양에 대한 인식과 병리론 崔昇勳
  37. 대한의학협회지 v.30 no.4 Colchicine이 마우스의 체액성및 세포성 면역반응에 미치는 영향 하대유(외)
  38. 대한의학협회지 v.27 no.6 고려인삼이 3-Methylanthrene의 발암능에 미치는 영향 하대유(외)
  39. 전북의대논문집 v.3 no.1 면적혈구 감작량이 Mlce의 지연형 과민반웅과 항체생산에 미치는 영향 하대유(외)
  40. 感氣丸이 白血病과 淋巴賤患者에서 抽出한 蘿細胞에 미치는 效果 韓相日
  41. 경희한의대논문집 v.18 no.1 보중익기탕, 수점산 및 보중익기탕합수점산의 항암과 면역조절 작용에 관한 실험적 연구 한성규;최승훈;안규석
  42. 제8회 국제동양의학 학술대회 Experimental Study of Shenllngbaichusan on Reducing Side effect of the Anti-cancer Agents. 한승섭;최승훈;안규석
  43. 大韓韓方腫瘍學會誌 v.2 no.1 全大縮湯 瓦松 및 十全大補湯加瓦松의 擺德效果와 免疫反感에 관한 硏究 翁臺東;拂逢夏;朴東源;梅基遠
  44. 中醫治崙大成 孟瑞升(등)
  45. 衛江中醫學院學報 v.12 no.3 扶正培本治在雇壇臨床上的應用 徐龍玉
  46. 第1回 東洋醫學國際 Symposium 發表論文集 中國 情統醫學에 의한 漂治療의方注 및 硏究近況 余桂淸
  47. 中藥藥理與應用 고浴生(主編)
  48. 中醫鍾壇學(上), 都仁存
  49. 抗感中草藥大辭典 劉春安;誇明(主編)
  50. 建國40年中醫科技成就 中醫藥防治痛症實驗硏究 丁瑞
  51. 段鳳舞緩痛積驗方 趙違成
  52. 精神因素與德症; 附200例臨床調査 v.8 no.3 趙景芳
  53. 四部備要 經部 周禮正義一 中華書局(編)
  54. Antibody formation at the cellular level in immunology. Avrames, S.(et al.)
  55. Cell Immuno v.3 no.1 Antigen recognition by T-lymphocytes I,thymmus and marrow dependence of spontaneous rosette forming cells in mouse. Bach,J.F.;Dardenne,M.
  56. Immuno v.14 no.7 A kinetic study of antibody producing cell in the spleen with sheeperythrocytes. Bozzi,G.(et al.)
  57. Eur. J. Immunol v.23 Carrier-mediated uptake and presentation of a major histocompatibility complex class I-restricted peptide. Brantier, C.(et al.)
  58. Soc. Exp.Biol.Med.Proc. v.122 Thymus marrow cell combination ,synergism in antibody production. Clamen,H.(et al.)
  59. Transplantation v.5 no.222 The failure of thymus derived cells to produce antibody. Davis,A,J.S.(et al.)
  60. J. Immunol Methods. v.15 A quick and simple method for the quantitation of lactate dehydrogenase release In measurements of cellular cytotoxicity and tumor necrosis factor(TNF)activity. Decker, T.(et al.)
  61. J. Immunol v.120 T cell growth factor;Parameters of production and a quantitatlve microassay for activity. Gillis, S.(et al.)
  62. J. Immunol. v.128 no.2 Studies on Induction and effector function of concanvalin A-Induced suppressor cells TCGF production. Cullberg, M.;Larsson, E. L.
  63. Eur. J. Immunol. v.5 Natural Killer cells in the mouse. Kiessling, R.(et al.)
  64. J, lmmunol. Methods v.64 no.31 An Enzyme-Release Assay for Natural Cytotoxicity. Korzeniewski, C.;Callewaert, D. M.
  65. J Nat. Cancer Inst. v.51 Immunopotentiation with BCG ll, Modulation of referance to the sheep red cells. Miller, T. E.(et al.)
  66. Immuno. v.13 Delayed hypersensitivity in mice induced by intravenous sensitization with sheep erythrocytes, evidence for tuberculin type delayed hypersensitivity of the reaction. Mitsuoka. A.(et al.)
  67. Antigen-Antibody interactions in baslc exorcises immuno-chemistry. Nowotny, A.
  68. Investigation of delayed hypersensitivity in man in Immunology. Revlllard, J.
  69. immunophathology and immunity Cell-mediated immunity in vitro inimmunology. Sell, S.
  70. J. Natl. Cancer Inst. v.78 Cytotoxic effects of free fatty acids on ascites tumor cells. Siegel, I.(et al.)
  71. Birt. J. Exp. Path. v.41 no.2 The affinity of the retiiculo-endotherial system farvorious serum proteins. Thorbeck, G. J.(et al.)
  72. Delayed hypersensitivity reaction in baslcand clinical immunology. Wing, E. J.(et al.)
  73. Nature v.202 A simple method for detecting single antibody forming cell. Zaalberg,O.B.